Masimo Corp (NASDAQ:MASI)

CAPS Rating: 5 out of 5

A global medical technology company that develops, manufactures and markets non-invasive patient monitoring products that improve patient care.

Recs

0
Player Avatar epimetavalent (< 20) Submitted: 10/19/2007 6:35:47 PM : Outperform Start Price: $27.16 MASI Score: -21.84

pure speculation.

Report this Post Reply

Featured Broker Partners


Advertisement